Table V.
Outcome of measurement of EuraHS-QoL score of patients – evaluation of TEP-IHR effectiveness
| EuraHS-QoL score | Preoperative | 12 months after operation | P-value |
|---|---|---|---|
| Pain domain, mean (range); all patients: | 7.62 (1–20) | 0.85 (0–8) | < 0.0001c |
| Pain domain, mean (range); in groups: | |||
| SG group | 7.33 (0–16) | 0.79 (0–8) | < 0.0001c |
| L group | 7.22 (1–15) | 0.38 (0–3) | < 0.0001c |
| LF group | 8.04 (0–20) | 1.08 (0–7) | < 0.0001c |
| Restrictions domain, mean (range); all patients: | 14.8 (0–38) | 0.77 (0–15) | < 0.0001c |
| Restrictions domain, mean (range); in groups: | |||
| SG group | 14.12 (0–34) | 0.69 (0–15) | < 0.0001c |
| L group | 12.61 (0–30) | 0.41 (0–2) | < 0.0001c |
| LF group | 16.29 (0–38) | 1.08 (0–12) | < 0.0001c |
c
Wilcoxon matched-pairs test; EuraHS-QoL score – max value 70; pain domain max. value 30; restrictions domain max. value 40.